Substitution Regulations

For healthcare practitioners prescribing or dispensing medicinal cannabis in Australia, it’s essential to understand the varying regulations that can impact patient outcomes — including dispensing substitution policies for these medications. In Australia, substitution policies for medicinal cannabis products vary across states and territories, with different rules governing schedule 4 & 8 medication substitutions at the pharmacy level. Per the Therapeutic Goods Administration (TGA), differences in medicinal cannabis products such as variations in brands or formulations can lead to different therapeutic effects. As a result, product substitution for these medicines is complex and should be guided by medical oversight and careful clinical judgment.¹

In jurisdictions where substitution without a new prescription is permitted, it is typically allowed under established protocols that ensure therapeutic consistency and clinical appropriateness for the patient. However, it is important to recognise that the concept of ‘generic substitution,’ common in conventional pharmaceuticals cannot be easily applied to medicinal cannabis. This is due to its natural variability in chemical composition and pharmacological effects. As such, it’s recommended that Pharmacists collaborate closely with Prescribers to ensure that any changes in a patient's medication maintain the original therapeutic intent. Whereby a coordinated approach rooted in a deep understanding of cannabinoid profiles and individual patient needs is crucial to preserving both treatment efficacy and patient support.

State & Territory Substitution Regulations 

In some Australian jurisdictions, substitution of medicinal cannabis products is permitted provided that specific prescription requirements are met per state or territory guidelines. In contrast, other states or territories prohibit any substitution unless the prescriber is consulted and makes the necessary prescription adjustments. Given that medicinal cannabis laws and regulatory frameworks continue to evolve, healthcare professionals including both prescribers and dispensers, must stay up to date with the latest guidelines relevant to their practice and their patients.

Substitution Regulations Download

Sign up to our mailing list to receive a complimentary outline of the substitution regulations per state and territory within Australia.

Reference List

¹ Therapeutic Goods Administration (2024). Special Access Scheme (SAS): Guidance for health practitioners accessing unapproved therapeutic goods [online]. Available from: https://www.tga.gov.au/resources/guidance/special-access-scheme-sas-guidance-health-practitioners-accessing-unapproved-therapeutic-goods